Welcome to the UPF Digital Repository

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria



Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

Thumbnail
Document Type: Article
Version: Accepted version
Date: 2018

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics

Compliant to Partaking